Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients.
about
Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapyMetabolism of a lipid nanoemulsion resembling low-density lipoprotein in patients with grade iii obesity.Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing miceEffect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Advances in non-invasive drug delivery for atherosclerotic heart disease.Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide.Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model.Evaluation of atherosclerotic lesions in cholesterol-fed mice during treatment with paclitaxel in lipid nanoparticles: a magnetic resonance imaging study.Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake.Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease.Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE).Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia.Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion.Formulation of LDL Targeted Nanostructured Lipid Carriers Loaded with Paclitaxel: A Detailed Study of Preparation, Freeze Drying Condition, andIn VitroCytotoxicity
P2860
Q26858849-C625F996-12F0-4C54-90E6-CCA15DDF2BCCQ33625979-F14E6CAD-1789-4737-8C96-51FE0E963701Q33719235-D8A92F30-ED3A-4899-AF33-A765E841A85CQ36518939-CC040908-FB8E-4FD8-BA40-808676123BABQ36677466-0F1F5A21-6689-4350-A06C-B200EE74400FQ37371188-A380B24B-E1AB-4344-8910-3185BE99D312Q38168361-AA983094-A228-4238-94D4-934A2FC1B00EQ38317205-2CD9BD60-B81D-4C53-B5CA-4D17BFC5EAD9Q39040956-3D5BE062-C13A-4447-B510-F4ABBF8395CBQ39461770-7B9DC109-4AB8-4E3C-8F92-342EE519F771Q39936738-2CAE995D-81A0-4D71-9C69-81A669D54796Q40596660-CE9F46A1-DD9D-475A-8FF9-2A872F5067ABQ41452570-A379919A-92F5-4A50-969A-06E39CE77D4FQ42045229-73865F5E-74C8-4FFB-BBEF-25691491F13CQ42081306-22AEDFF9-3D21-4D9C-B266-A3C8351BD78EQ44300093-A3ADC219-D989-4D23-8CB3-E2CECC9B4F95Q44963441-8B085048-F3F2-4255-A8A6-9B2565CFA9ACQ45155125-8E71A3A1-BF6D-4D89-A5DC-9E88944A3D8BQ48012324-A69D5ADE-EBE8-43E8-B4D9-E924676AE860Q51507063-5B930014-A93D-47BC-AEE0-8A65A0EB768DQ51743444-A2CDA44F-279C-4373-A797-6676511DB2FAQ53598744-B44DD3C4-888D-497D-9A9D-5A6686DE0414Q53620531-5F5072EB-E957-4758-A396-9D5AD9D3B03DQ58909613-48B07389-5F66-4255-AC19-8A1AC90881D7
P2860
Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Association of carmustine with ...... ry studies in cancer patients.
@ast
Association of carmustine with ...... ry studies in cancer patients.
@en
type
label
Association of carmustine with ...... ry studies in cancer patients.
@ast
Association of carmustine with ...... ry studies in cancer patients.
@en
prefLabel
Association of carmustine with ...... ry studies in cancer patients.
@ast
Association of carmustine with ...... ry studies in cancer patients.
@en
P2093
P1476
Association of carmustine with ...... ry studies in cancer patients.
@en
P2093
Antonio C Buzaid
Debora G Rodrigues
Maria C Latrilha
Ricardo D Couto
Roberto F Melo
Shirley Schreier
Silvia R Graziani
P2888
P304
P356
10.1007/S00280-002-0437-3
P577
2002-03-21T00:00:00Z
P6179
1010294838